Survodutide is a next-generation dual agonist peptide designed to support advanced weight-management and metabolic wellness research. By targeting both GLP-1 and glucagon receptor pathways, Survodutide has gained significant attention in the body composition and metabolic health space. As one of the most promising compounds in modern weight-management research, Survodutide continues to attract interest from researchers focused on appetite regulation, metabolic wellness, and healthy weight-management strategies.